CVT
13/11/2015 15:02
GENERAL
NOT PRICE SENSITIVE
REL: 1502 HRS Comvita Limited
GENERAL: CVT: Completion of buy back of escrow stock
The attached announcement gives effect to the share buy back from escrow
shares which were held for part settlement to members of the NZ Honey
Producers Co-operative Limited. The details of this buy back were announced
to the market on 20 October 2015.
Ends
For further information:
Scott Coulter, Comvita Chief Executive, Ph. 021 386 988
Neil Craig, Comvita Chair, Ph. 021 731 509
About Comvita (www.comvita.co.nz)
Comvita (NZX:CVT) is a global natural health company committed to the
development of innovative products, backed by ongoing investment in
scientific research. We are the world leaders in Manuka (leptospermum) honey
and fresh-picked Olive Leaf Extract, which are at the core of the Comvita
product range.
We have approximately 50% of honey supply under direct ownership or control,
with the balance of supply from long term contractual and partnership
arrangements. Comvita pioneered the development and use of medical grade
Manuka honey and was the first to receive FDA approval (2007). We partner
with US wound care company Derma Sciences, Inc. (NASDAQ:DSCI), the global
licensee for Medihoney specialist wound care products, which are used in
hospitals and medical centres around the world. Comvita's freshly picked
Olive Leaf Extract is grown, harvested, extracted and bottled at the world's
largest specialised olive leaf grove, with over one million olive trees.
Comvita sells into more than 18 countries through a network of our own
branded retail locations, online (seven country specific e-commerce websites)
and third-party outlets. We have over 500 staff located in New Zealand,
Australia, Hong Kong, Japan, South Korea, the United Kingdom and the USA.
End CA:00273421 For:CVT Type:GENERAL Time:2015-11-13 15:02:36
